Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article - Biomedical Research (2017) Volume 28, Issue 15

Association of serum Aβ1-42, cystatin C and UA with parkinson's disease

Objective: This study is to investigate the association of β-amyloid 1-42 (Aβ1-42), Cystatin C (Cys C), Uric Acid (UA) with Parkinson’s disease (PD).

Methods: A total of 108 PD patients and 108 healthy individuals were enrolled. The serum levels of Aβ1-42, Cys C and UA were measured. The Operating Characteristic Curve (ROC) was drawn, and then the Area Under the Curve (AUC), 95% Confidence Interval (CI), sensitivity and specificity were calculated.

Results: Serum Aβ1-42 and UA levels in PD patients were significantly lower than those in healthy controls. Serum Cys C level in PD patients was significantly higher. The AUC of Aβ1-42 was 0.644, 95% CI was 0.570~0.718, diagnostic sensitivity and specificity were 52.8% and 74.1% and the cut-off point was 0.912 μg/L. The AUC of UA was 0.633, 95% CI was 0.557~0.708, sensitivity and specificity were 65.7% and 64.8% and the cut-off point was 281 μmol/L. Serum UA in male PD patients was significantly higher than that in female PD patients. Serum Cys C in PD patients were significantly higher than that in healthy controls. Serum Aβ1-42 was negatively correlated with HY grade. Serum Cys C was positively correlated with HY grade. Serum UA was negatively correlated with HY classification, UPDRS score and the III scores.

Conclusion: Serum Aβ1-42 and UA may contribute to PD diagnosis. Cystatin C may be involved in the development of PD and be helpful in assessing the PD severity.

Author(s): Jing Lei, Jianhua Ma, Ruobing Liang, Xiaoning Zhang

Abstract Full Text PDF